Fig. 3 | Scientific Reports

Fig. 3

From: Identification of foam cell like M2 macrophages, AEBP1 biomarkers, and resveratrol as potential therapeutic in MASLD using Ecotyper and WGCNA

Fig. 3

Differentially expressed (A) Fibroblasts.3 and (B) Macrophages.6 were positively associated with MASH fibrosis severity in GSE135251. The comparison between disease groups was conducted by the Kruskal-Wallis Analysis of Variance (ANOVA) test with adjusted P values. MASLD: metabolic dysfunction–associated steatotic liver disease. MASH: metabolic dysfunction-associated steatohepatitis.

Back to article page